From record-breaking litigation wins to billion-dollar deals and global policy leadership, this year’s cohort features the ...

WilmerHale trade secrets expert moves to new firm ...

UPC revives patent, but timing sinks Guardant’s appeal ...

Otsuka v Sun Pharma could redefine which pharmaceutical patents qualify for patent term extensions, with major implications ...

Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of ...

HGF expands European offering with pair of in-house hires ...

A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over ...

Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm ...

Ashurst Perkins Coie opens its doors following landmark merger ...

Despite the flexibilities embedded in the TRIPS Agreement and reaffirmed by the Doha Declaration, timely access to vaccines ...

A new report warns that sweeping procurement reforms in Mainland China, alongside open robotics platforms, supply chain disruption and GLP-1 drugs, are changing competition and challenging ...